Corporate Advisory Board Member
A life science executive with almost 30yrs experience, Brian O'Callaghan has lived and worked in 5 different countries, as well as both sides of the US. Senior Management, CEO and Board experience with multiple Biotech, Big Pharma and CRO companies, within both Europe and the US.
He has tremendous experience with public and private companies, all stages of development and commercialization, business development, M&A, fundraising and IPO's.
In June 2020, his company Petra Pharma was acquired by Eli Lilly and Company for $4.3B.